ID: ALA423778

Max Phase: Preclinical

Molecular Formula: C11H15NOS

Molecular Weight: 209.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@H](CS)Cc1ccccc1

Standard InChI:  InChI=1S/C11H15NOS/c1-9(13)12-11(8-14)7-10-5-3-2-4-6-10/h2-6,11,14H,7-8H2,1H3,(H,12,13)/t11-/m0/s1

Standard InChI Key:  MIIWZLSUWIYCIH-NSHDSACASA-N

Associated Targets(Human)

Beta-chymotrypsin 261 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 209.31Molecular Weight (Monoisotopic): 209.0874AlogP: 1.66#Rotatable Bonds: 4
Polar Surface Area: 29.10Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.04CX Basic pKa: CX LogP: 1.67CX LogD: 1.67
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.73Np Likeness Score: -0.09

References

1. Han MS, Oh DJ, Kim DH..  (2004)  Inhibition of alpha-chymotrypsin with thiol-bearing substrate analogues in the presence of zinc ion.,  14  (3): [PMID:14741272] [10.1016/j.bmcl.2003.11.058]

Source